| OTHER NOTES :
1. The manufacturing operations in the Companys plant located at Plot
No. R-274, M.I.D.C., T.T.C. Industrial Area, Rabale, Thane Belapur
Road, Thane-400 701, remained suspended consecutively for the second
year and plant & Machineries installed thereon have been dismantled.
The Company has no intention to start the pharmaceutical manufacturing
activity at said Plant. However the company is planning to continue
the manufacturing activities only on loan license basis, the accounts
of the company have been prepared on the concept that the company will
continue as a going concern.
2. Sundry Debtors includes Rs. 26.83 Lacs (Previous Year Rs. 25.64
Lacs), and Loans & Advances to suppliers & others includes Rs. 33.77
Lacs (Previous Year Rs. 23.17 Lacs), which are outstanding for the
period exceeding two year and are doubtful of recovery. In the opinion
of he Management the said amounts are good and recoverable and no
provision is considered necessary in the accounts.
3. The Company has given guarantees to the extent of Rs. 30.00 crores
during the year to Global trust Bank Ltd. out of the above guarantees
given, sanction from members was obtained to the extent of Rs. 20.00
Crores.
4. The Company has pledged 4.00 Lacs shares of Agee Gold Refiners Ltd.
included in Investments as a collateral security with Global Trust Bank
Ltd. for the term loan facility availed by another Company.
5. Confirmations have not been obtained from certain parties in
respect of Unsecured Loans, Loans & Advances, Sundry Deposit, Sundry
Debtors and Sundry Creditors.
6. Auditors Remuneration :
Year ended Year ended
31.03.2001 31.03.2000
(Rs.) (Rs.)
Audit Fees 20,000 20,000
Certification Fees 1,000 NIL
21,000 20,000
7. In the absence of assessable profit, no provision for taxation is
made in the accounts.
8. Contingent Liabilities :
a) The Central excise demand against which the Company has preferred an
appeal amounting to Rs. 20,04,755/- (Previous Year Rs. 6,34,895/-).
b) The Income Tax demand against which the Company has preferred an
appeal amounting to Rs. 1,89,192/- (Previous Year Rs. 1,89,192/-).
c) Bank Guarantee in favor of Global trust Bank for Term Loan to Agee
Gold Refiners Ltd. to the extent of Rs. 30.00 crores (Previous Year Rs.
NIL).
9. Previous year figures have been regrouped wherever necessary.
10. ADDITIONAL INFORMATION IN PURSUANT TO PART it OF SCHEDULE VI OF THE
COMPANIES ACT, 1956.
I) Manufacturing Activities
(a) Particulars of Production, Stock and Sales (Rs. in Lacs)
Formulation Unit Opening Stock Production
01.04.2000 2000-2001
Qty. Value Qty.
1. Liquid Injectible Ltrs. 0.000 0.000 1808.720
and Eye/Ear drops (253.255) (4.660) (0.000)
2. Capsules No. in 0.000 0.000 288.260
000 (181.022) (6.224) (0.000)
3. Tablets Million 0.000 0.000 3.489
Nos. (0.73) (8.696) (0.000)
4. Liquid Oral 0.000 0.000 0.000
Ltrs. (83.00) (0.012) (0.000)
TOTAL 0.000
(19.592)
Goods Returned Turnover
During the year During the year
Qty. Value Qty. Value
108,486 1,956 1,283,660 12.44
(46,716) (0.873) (277.29) (3.535)
48.75 1.571 98,800 0.711
(58,146) (1.758) (40.54) (0.455)
221.516 4.151 1.843 5.604
(0.325) (4.199) (0.684) (3.733)
0.850 0.000 0.000 0.000
(26.00) (0.004) (0.000) (0.000)
7.678 18.655
(6.834) (7.723)
Free Samples Written Off Closing Stock
As on 31.03.2001
Qty. Value Qty. Value Qty. Value
0.000 0.000 108,486 1.956 525,060 5.070
(0.206) (0.004) (22,476) (0.426) (0.000) (0.000)
0.000 0.000 48.750 1.571 189.460 1.360
(0.10) (0.003) (198,528) (7.194) (0.000) (0.000)
0.000 0.000 221,516 4.151 1.646 7.140
(0.000) (0.000) (0.371) (4.343) (0.000) (0.000)
0.000 0.000 0.850 0.000 0.000 0.000
(0.000) (0.000) (109,000) (0.017) (0.000) (0.000)
0.000 7.678 13.570
(0.007) (11.980) 0.000
(b) Consumption of Raw Material & Packing Material
For the Year ended For the year ended
31.03.2001 31.03.2000
Qty. Value Qty. Value
(Rs. in lacs) (Rs. in lacs)
Pharma Bulk Drug & excipients
(Units in kg) 420.40 12.27 Nil Nil
Others Nil 10.14 Nil Nil
22.41 Nil
(c) Consumption of Imported and Indigenous Raw & Packing Materials
For the Year ended For the year ended
31.03.2001 31.03.2000
Value % of total Value % of total
(Rs. in lacs) Consumption (Rs. in lacs.) Consumption
Indigenous 22.41 100% NIL NIL
II. Trading Activities
Particulars of Opening Stock, Closing Stock, Purchases and Sales
Opening Stock Transfer from
Class of Goods Opening Stock
01.04.2000 of Material
Qty. Value Qty. Value
1. Pharma Bulk Drugs & Nil Nil 71,638 0.095
Excipients (Units in kg) (Nil) (Nil) (193.58) (0.28)
2 Others Nil Nil 60315 0.294
(Units in Nos) (Nil) (Nil) (16,525) (0.54)
Nil 0.389
(Nil) (034)
Purchases Sales Closing Stock
During the year During the year As At
31.03.2001
Qty. Value Qty. Value Qty. Value
Nil Nil 71.638 0.095 Nil Nil
(Nil) (Nil) (193.58) (0.170) (Nil) (Nil)
Nil Nil 60315 0.322 Nil Nil
(Nil) (Nil) (16,525) (0.054) (Nil) (Nil)
Nil 0.417 Nil
(Nil) (0.224) (Nil)
11. CIF value to import Rs. Nil (Previous Year Rs. Nil)
12. Expenditure on Foreign Currency Rs. Nil (Previous Year Rs, NIL)
13. F.O.B. value of Exports Rs. NIL (Previous Year Rs. NIL)
14. Amount including interest if any, due to Small Scale and Ancillary
undertaking if any, could not be disclosed as such parties could not be
identified from the records of the Company.
15 Managerial Remuneration.
Year ended Year ended
31.03.2001 31.03.2000
Salary NIL 254,940
Contribution to PF NIL 18,216
Other Perquisites & Allowances 13,725 146,575
13,725 419,731
16. Additional information as required under part IV of Schedule VI
to the Companies Act, 1956 is annexed herewith.
| 